Holtzman receives grant to develop drug treatment for respiratory diseases

Michael J. Holtzman, MD, the Selma and Herman Seldin Professor of Medicine and director of the Division of Pulmonary & Critical Care Medicine at the School of Medicine, has received a 2020 Scholar-Innovator Award from the Harrington Discovery Institute at University Hospitals in Cleveland. He is one of six physician-scientists from the U.S. and Canada selected for a grant supporting drug development. The grant provides a total of $100,000 in funding for a new drug to correct stem cell reprogramming in the lining of the airway, in an effort to improve treatment of respiratory diseases.